IDERA PHARMACEUTICALS, INC. (IDP) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 221 transactions totaling $24.9M, demonstrating a bearish sentiment with -$24.7M in net insider flow. The most recent transaction on Jul 29, 2008 involved a sale of 19,670 shares valued at $293.7K.
No significant insider buying has been recorded for IDP in the recent period.
No significant insider selling has been recorded for IDP in the recent period.
Based on recent SEC filings, insider sentiment for IDP is bearish with an Insider Alignment Score of 0/100 and a net flow of -$24.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IDERA PHARMACEUTICALS, INC. (IDP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading IDP stock, having executed 221 transactions in the past 90 days. The most active insider is Julian Baker (Executive), who has made 50 transactions totaling $10.9M.
Get notified when executives and directors at IDP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 29, 2008 | Life Sciences Capital (gp), Llc Baker Brothers | Executive | Sale | 19,670 | $14.93 | $293.7K | |
| Jul 29, 2008 | Capital (gp), Llc Baker Bros. | Executive | Sale | 1,885 | $14.93 | $28.1K | |
| Jul 29, 2008 | Baker Felix | Executive | Sale | 19,670 | $14.93 | $293.7K | |
| Jul 29, 2008 | Capital (gp), Llc Baker Biotech | Executive | Sale | 9,839 | $14.93 | $146.9K | |
| Jul 29, 2008 | Baker Julian | Executive | Sale | 606 | $14.93 | $9.0K | |
| Jul 29, 2008 | (gp), Llc 14159 Capital | Executive | Sale | 606 | $14.93 | $9.0K | |
| Jul 29, 2008 | Life Sciences Capital (gp), Llc Baker Brothers | Executive | Sale | 19,670 | $14.93 | $293.7K | |
| Jul 29, 2008 | Capital (gp), Llc Baker Bros. | Executive | Sale | 1,885 | $14.93 | $28.1K | |
| Jul 29, 2008 | Capital (gp), Llc Baker Biotech | Executive | Sale | 9,839 | $14.93 | $146.9K | |
| Jul 28, 2008 | Life Sciences Capital (gp), Llc Baker Brothers | Executive | Sale | 5,901 | $14.87 | $87.7K | |
| Jul 28, 2008 | Capital (gp), Llc Baker Bros. | Executive | Sale | 565 | $14.87 | $8.4K | |
| Jul 28, 2008 | Baker Felix | Executive | Sale | 5,901 | $14.87 | $87.7K | |
| Jul 28, 2008 | Capital (gp), Llc Baker Biotech | Executive | Sale | 2,952 | $14.87 | $43.9K | |
| Jul 28, 2008 | Baker Julian | Executive | Sale | 182 | $14.87 | $2.7K | |
| Jul 28, 2008 | (gp), Llc 14159 Capital | Executive | Sale | 182 | $14.87 | $2.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 179 | $24.8M | 99.4% |
Purchase(P) | 22 | $108.7K | 0.4% |
Exercise(M) | 14 | $34.5K | 0.1% |
Award(A) | 2 | $1.6K | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insider selling pressure at IDERA PHARMACEUTICALS, INC. has increased, with 12 insiders executing 221 transactions across all time. Total sales of $24.8M significantly outpace purchases of $108.7K, resulting in a net outflow of $24.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.